Contact Us
Pay Invoice
Follow Us!
Latest Blogs
- March Is Colorectal Cancer Awareness Month: How Liquid Biopsy Is Shaping the Future of CRC Detection and Care February 20, 2026
- Global IVD Growth: Stability, Shifting Markets, and the Road to 2030 February 11, 2026
- Cell and Gene Therapy at a Turning Point January 30, 2026
- Sepsis Gap & Home Testing Growth: Interview with Kalorama Information’s Daniel Granderson January 9, 2026
- What Is the Size of the IVD Market in 2025? September 8, 2025
Sitemap
Your Data and Privacy
About Us
Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.
Visit Science and Medicine Group
Visit Science and Medicine Group
COVID-19 Testing Increases Demand in $150 Billion Clinical Laboratory Services Market, Future Growth Linked to Global Economies
The global market for clinical laboratory services grew to an estimated $150.4 billion during 2020, with COVID-19 testing demand increasing the market by more than $26 billion over the year. These findings are according to insights featured in Clinical Laboratory Services Market, 6th Edition, a new report by leading medical market research publisher Kalorama […]
Molecular Diagnostics Market to Reach 28 Billion. We Didn’t Predict That Two Years Ago.
The market for DNA-based tests used for clinical diagnostic purposes has exceeded previous forecasting, due to the COVID-19 crisis. Mid 2019, Kalorama Information’s report projected the market size (all DNA-based tests, revenues to IVD companies) would reach 10.1 billion. We also estimated cancer would be the driver. Instead, Kalorama now projects that market to be […]
Oncologists Urge Faster Biomarker Results for Lung Cancer Patients
Diagnostic testing companies should do a better job of turning around biomarker test results for lung cancer patients, according to a survey reported at the American Society of Clinical Oncology (ASCO) annual meeting on June 4. Out of 170 clinicians polled, the vast majority (98%) said that they felt it was important to get biomarker […]
China Emerging as Vital Point of Care (POC) Market
Reforms in China, along with increasing incidence of cancer, diabetes, heart disease and infectious diseases such as HIV, hepatitis and STDs, provide new opportunities for point-of-care, advanced tests and molecular diagnostics, reports medical market research publisher Kalorama Information. China’s potential as a point of care (POC) market was already growing when the coronavirus […]
AACC releases guidance on kidney injury lab testing
The American Association for Clinical Chemistry (AACC) released guidance on lab testing for acute kidney injury (AKI) patients that proposes new diagnostic thresholds for whether a patient has AKI with creatinine testing. One of the major recommendations is to propose that clinicians use the 20/20 AACC acute kidney injury criteria to determine whether a patient […]
Infographic: Kalorama Information’s Guide to Diagnostic Biomarkers
This infographic is based on the report The World Market for Diagnostic Biomarkers (Tumor, Cardiac, Infectious Disease, AutoImmune, Others) by leading medical market research publisher Kalorama Information. Purchase the report for more insights on the past, present, and future of this important market.
Remote Patient Monitoring and Telehealth: 5 Years of Growth Forecast for $54 Billion Market
Before COVID-19, the telehealth industry was evolving slowly with slight gains annually. Today, the pandemic has thrust the world into a new era of remote life, including managing, monitoring and treating patients and their health conditions at a pace never experienced before. As a result of COVID-19, the global market for patient monitoring and […]
3 Growth Trends in $472 Billion Global Medical Device Market
COVID-19, mergers & acquisitions, and innovation spurred notable gains in the sale of medical devices in 2020 The global market for medical devices rose to $472 billion in 2020, increasing 5.1% for the year over 2019, according to new data published in The Global Market for Medical Devices, 11th Edition, the latest report […]
At-Home Testing Expanding Reach Beyond COVID-19 Pandemic
Over the years, the increasing introduction of transportable, portable, and handheld medical instruments has resulted in the migration of point-of-care (POC) testing from the hospital environment to a range of medical and non-medical environments including the workplace, home, disaster care and most recently, convenience clinics. In the face of the ongoing global COVID-19 pandemic, the […]
Point of Care Test Market is Ravaged, and Helped By Pandemic
Kalorama Information reported a mixed result with point of care testing, defined by tests that can deliver a result meaningful during a patient visit with a provider or on their own. In 2020, sales of POC testing reached $29,316 million, according to Kalorama Information, a sister publication to Lab Pulse. That’s up double digits from […]